Literature DB >> 15797933

Effects of statins on endothelial function and lipid profile in HIV infected persons receiving protease inhibitor-containing anti-retroviral combination therapy: a randomised double blind crossover trial.

D Hürlimann, R Chenevard, F Ruschitzka, M Flepp, F Enseleit, M Béchir, R Kobza, J Muntwyler, B Ledergerber, T F Lüscher, G Noll, R Weber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15797933      PMCID： PMC1860959          DOI： 10.1136/hrt.2004.056523

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study.

Authors:  D Périard; A Telenti; P Sudre; J J Cheseaux; P Halfon; M J Reymond; S M Marcovina; M P Glauser; P Nicod; R Darioli; V Mooser
Journal:  Circulation       Date:  1999-08-17       Impact factor: 29.690

2.  Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease.

Authors:  V Schächinger; M B Britten; A M Zeiher
Journal:  Circulation       Date:  2000-04-25       Impact factor: 29.690

3.  Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction.

Authors:  J H Stein; M A Klein; J L Bellehumeur; P E McBride; D A Wiebe; J D Otvos; J M Sosman
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

4.  Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047.

Authors:  Carl J Fichtenbaum; John G Gerber; Susan L Rosenkranz; Yoninah Segal; Judith A Aberg; Terrence Blaschke; Beverly Alston; Fang Fang; Bradley Kosel; Francesca Aweeka
Journal:  AIDS       Date:  2002-03-08       Impact factor: 4.177

5.  Combination antiretroviral therapy and the risk of myocardial infarction.

Authors:  Nina Friis-Møller; Caroline A Sabin; Rainer Weber; Antonella d'Arminio Monforte; Wafaa M El-Sadr; Peter Reiss; Rodolphe Thiébaut; Linda Morfeldt; Stephane De Wit; Christian Pradier; Gonzalo Calvo; Matthew G Law; Ole Kirk; Andrew N Phillips; Jens D Lundgren
Journal:  N Engl J Med       Date:  2003-11-20       Impact factor: 91.245
  5 in total
  25 in total

Review 1.  Lipodystrophy: pathophysiology and advances in treatment.

Authors:  Christina G Fiorenza; Sharon H Chou; Christos S Mantzoros
Journal:  Nat Rev Endocrinol       Date:  2010-11-16       Impact factor: 43.330

Review 2.  Endothelial dysfunction in HIV infection.

Authors:  Bruno R Cotter
Journal:  Curr HIV/AIDS Rep       Date:  2006-09       Impact factor: 5.071

3.  Safety and Impact of Low-dose Methotrexate on Endothelial Function and Inflammation in Individuals With Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314.

Authors:  Priscilla Y Hsue; Heather J Ribaudo; Steven G Deeks; Tanvir Bell; Paul M Ridker; Carl Fichtenbaum; Eric S Daar; Diane Havlir; Eunice Yeh; Ahmed Tawakol; Michael Lederman; Judith S Currier; James H Stein
Journal:  Clin Infect Dis       Date:  2019-05-17       Impact factor: 9.079

4.  Brachial Artery Echogenicity and Grayscale Texture Changes in HIV-Infected Individuals Receiving Low-Dose Methotrexate.

Authors:  James H Stein; Eunice Yeh; Joanne M Weber; Claudia Korcarz; Paul M Ridker; Ahmed Tawakol; Priscilla Y Hsue; Judith S Currier; Heather Ribaudo; Carol K C Mitchell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-12       Impact factor: 8.311

Review 5.  Human Immunodeficiency Virus Infection, Antiretroviral Therapy, and Statin: a Clinical Update.

Authors:  Hugo Ribeiro Zanetti; Leonardo Roever; Alexandre Gonçalves; Elmiro Santos Resende
Journal:  Curr Atheroscler Rep       Date:  2018-02-08       Impact factor: 5.113

6.  Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-infected Children, Adolescents and Young Adults With Hyperlipidemia.

Authors:  Ann J Melvin; Grace Montepiedra; Lisa Aaron; William A Meyer; Hans M Spiegel; William Borkowsky; Mark J Abzug; Brookie M Best; Marilyn J Crain; Peggy R Borum; Bobbie Graham; Patricia Anthony; Katherine Shin; George K Siberry
Journal:  Pediatr Infect Dis J       Date:  2017-01       Impact factor: 2.129

Review 7.  Pediatric Statin Administration: Navigating a Frontier with Limited Data.

Authors:  Jonathan Wagner; Susan M Abdel-Rahman
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Sep-Oct

Review 8.  Understanding and controlling chronic immune activation in the HIV-infected patients suppressed on combination antiretroviral therapy.

Authors:  Babafemi Taiwo; Luis Barcena; Randall Tressler
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

Review 9.  Statins to improve cardiovascular outcomes in treated HIV infection.

Authors:  Chris T Longenecker; Allison R Eckard; Grace A McComsey
Journal:  Curr Opin Infect Dis       Date:  2016-02       Impact factor: 4.915

10.  Are HIV positive patients resistant to statin therapy?

Authors:  Kevin W Johns; Matthew T Bennett; Gregory P Bondy
Journal:  Lipids Health Dis       Date:  2007-10-24       Impact factor: 3.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.